Survivin—An attractive target for RNAi in non-Hodgkin's lymphoma, Daudi cell line as a model

References

• Amborosini G, Adida C, Altieri D C. A novel anti-apopotsis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917–921
   PubMed Web of Science ®Google Scholar
• Tamm I, Wang Y, Sausville E, Scudiero D A, Vigna N, Oltersdorf T, Reed J C. IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58(23)5315–5320
   PubMed Web of Science ®Google Scholar
• Li F, Ambrosini G, Chu E Y, Plescia J, Tognin S, Marchisio P C, Altieri D C. Control of apoptosis and mitotic spindle checkpoint by Survivin. Nature 1998; 396(6711)580–584
   PubMed Web of Science ®Google Scholar
• Monzo M, Rosell R, Felip E, Astudillo J, Sanchez J J, Maestre J, et al. A novel anti-apoptosis gene: re-expression of Survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 1999; 17(7)2100–2104
   PubMed Web of Science ®Google Scholar
• Swana H S, Grossman D, Anthony J N, Weiss R M, Altieri D C. Tumor content of the antiapoptosis molecule Survivin and recurrence of bladder cancer. N Engl J Med 1999; 341(6)452–453
   PubMed Web of Science ®Google Scholar
• Jacobson J O, Wilkes B M, Kwaiatkowski D J, Medeiros L J, Aisenberg A C, Harris N L. Bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Cancer 1993; 72: 231–236
   PubMed Web of Science ®Google Scholar
• Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez J M, Hossfeld D K, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t (11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601–3609
   PubMed Web of Science ®Google Scholar
• Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 2000; 96(5)1921–1925
   PubMed Web of Science ®Google Scholar
• Ansell S M, Arendt B K, Grote D M, Jelinek D F, Novak A J, Wellik L E, et al. Inhibition of Survivin expression surppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia 2004; 18(3)616–623
   PubMed Web of Science ®Google Scholar
• Izquierdo M. Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther 2005; 12: 217–227
   PubMed Web of Science ®Google Scholar
• Olie R A, Sim[otilde]es-Wüst A P, Baumann B, Leech S H, Fabbro D, Stahel R A, Zangemeister-Wittke U. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 2000; 60: 2805–2809
   PubMed Web of Science ®Google Scholar
• Ambrosini G, Adida C, Sirugo G, Altireri D C. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 1998; 273: 11177–11182
   PubMed Web of Science ®Google Scholar
• Mesri M, Wall N R, Li J, Kim R W, Altieri D C. Cancer gene therapy using a survivin mutant adneovirus. J Clin Invest 2001; 108: 981–990
   PubMed Web of Science ®Google Scholar
• Pennati M, Colella G, Folini M, Citti L, Daidone M G, Zaffaroni N. Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J Clin Invest 2002; 109: 285–286
   PubMed Web of Science ®Google Scholar
• Pennati M, Campbell A J, Curto M, Binda M, Cheng Y, Wang L Z, et al. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol Cancer Ther 2005; 4(9)1328–1337
   PubMed Web of Science ®Google Scholar
• Carvalho A, Carmena M, Sambade C, Earnshaw W C, Wheatley S P. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J Cell Sci 2003; 116: 2987–2998
   PubMed Web of Science ®Google Scholar
• Paddison P J, Caudy A A, Bernstein E, Hannon G J, Conklin D S. Short hairpin RNAs (shRNA) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16: 948–958
   PubMed Web of Science ®Google Scholar
• Brummelkamp T R, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553
   PubMed Web of Science ®Google Scholar
• Xiang L, Fengzhi L. Silencing of antiapoptotic Survivin gene by multiple approaches of RNA interference technology. BioTechniques 2004; 36: 450–460
   PubMed Web of Science ®Google Scholar
• Czauderna F, Fechtner M, Aygun H, Amold W, Kippel A, Giese K, Kaufmann J. Functional studies of the PI(3)-kinase signaling pathway employing synthetic and expressed shRNA. Nucleic Acid Res 2003; 31: 670–682
   PubMed Web of Science ®Google Scholar
• Cheng S Q, Wang W L, Yan W, Li Q L, Wang L, Wang W Y. Knockdown of Survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721. World J Gastroenterol 2005; 11(5)756–769
   PubMed Web of Science ®Google Scholar
• Carvalho A, Carmena M, Sambade C, Earnshaw W C, Wheatley S P. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J Cell Sci 2003; 116(Pt 14)2987–2998
   PubMed Web of Science ®Google Scholar
• Williams N S, Gaynor R B, Scoggin S, Verma U, Gokaslan T, Simmang C, et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 2003; 9(3)931–946
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu H, Quan L, Zhou C, Bai J, Zhang G, et al. Downregulation of Survivin by RNAi inhibits the growth of esophageal carcinoma cells. Cancer Biol Ther 2005; 4(9)974 – 978
   PubMed Web of Science ®Google Scholar
• Chawla-Sarkar M, Bae S I, Reu F J, Jacobes B S, Lindner D J, Borden E C. Downregulation of Bcl-2, FLIP or IAPs (XIAP and Survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ 2004; 11(8)915–923
   PubMed Web of Science ®Google Scholar
• Kappler M, Bache M, Bartel F, Kotzsch M, Panian M, Wurl P, et al. Knockdown of Survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther 2004; 11(3)186–193
   PubMed Web of Science ®Google Scholar
• Kappler M, Taubert H, Bartel F, Blumke K, Panian M, Schmidt H, et al. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wtp53 sarcoma cell line, but not in a mt-p53 sarcoma cell line. Oncol Rep 2005; 13: 167–172
   PubMed Web of Science ®Google Scholar
• Mazur G, Halon A, Wrobel T, Urbaniak J, Kuliczkowski K, Wozniak M. Survivin expression in lymph nodes, affected by lymphoma and reactive hyperplasia. Rocz Akad Med Bialymst 2004; 49(Suppl 1)76–78
   PubMedGoogle Scholar